Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients-Reference-Cited by-同舟云学术

Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients

Published:2015 Issue:4 Volume:18 Page:365
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Kim Hee Jeong¹,Yoon Tae-In¹,Chae Hee Dong²,Kim Jeong Eun³,Chae Eun Young⁴,Yu Jong Han¹,Sohn Guiyun¹,Ko Beom Seok¹,Lee Jong Won¹,Son Byung Ho¹,Ahn Sei Hyun¹

Affiliation:

1. Division of Breast and Endocrine Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

2. Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

3. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

4. Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funder

Korea Breast Cancer Foundation

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

https://synapse.koreamed.org/pdf/10.4048/jbc.2015.18.4.365

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy combined with endocrine therapy: Old wine in a new bottle?;Clinical Breast Cancer;2024-08

2. Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis;Medicine;2023-11-17

3. Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy;World Journal of Clinical Cases;2023-09-26

4. Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK/JUP signalling;Cell Death & Disease;2023-06-16

5. Time to surgery and survival in breast cancer;BMC Surgery;2022-11-11